Fig. 1From: Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trialProportion of patients who converted to sinus rhythm. Proportion of patients who converted to sinus rhythm within 90 min of the start of the first infusion of placebo or vernakalantBack to article page